We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Understanding the measurement properties of the incremental shuttle walk test in patients with severe asthma.
- Authors
Majd, Sally; Hewitt, Stacey M.; Apps, Lindsay D.; Murphy, Anna C.; Bradding, Peter; Singh, Sally J.; Green, Ruth H.; Evans, Rachael A.
- Abstract
Background and objective: We investigated the repeatability and validity of the incremental shuttle walk test (ISWT) distance compared to peak oxygen uptake (VO2pk) during maximal incremental cycle ergometer (ICE) and treadmill (ITM) tests in adults with severe asthma. Methods: Adults with severe asthma, Medical Research Council (MRC) dyspnoea ≥2, were recruited from specialists caring for patients with severe asthma. All participants performed three ISWT (familiarization and two subsequent tests on the same day), an ICE and an ITM in a randomized order, on separate days, to intolerance with expiratory gas analysis. Results: A total of 50 patients (32 females, mean (SD), age: 54 (13) years, forced expiratory volume in 1 s (FEV1): 1.9 (0.8) L and body mass index (BMI): 32 (6) kg/m2) completed all five tests. The mean (SD) ISWT distance for each test was 400 (156), 418 (142) and 438 (157) m (P = 0.001), respectively. There was a strong correlation between the ISWT distance with VO2pk derived from ITM (r = 0.74, P < 0.001) and ICE (r = 0.75, P < 0.001). Conclusion: There was a small increase in the mean ISWT distance on sequential testing. In clinical practice, the coefficient of repeatability and heteroscedasticity need to be considered when assessing whether a true change has occurred within an individual patient. The ISWT has validity compared to VO2pk on both ICE and ITM, but they are not interchangeable. The measurement properties of the incremental shuttle walk test (ISWT) are unknown in patients with severe asthma. The study results show ISWT can be used to assess exercise capacity in patients with severe asthma. However, the small increase in distance on repeated testing would need to be considered in non‐randomized trials. See relatedEditorial
- Subjects
MEDICAL Research Council (Great Britain); ASTHMATICS; BODY mass index; GAS analysis
- Publication
Respirology, 2019, Vol 24, Issue 8, p752
- ISSN
1323-7799
- Publication type
Article
- DOI
10.1111/resp.13519